Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.

Publikation

Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.

Wissenschaftlicher Artikel/Review - 01.07.2023

Filippidis Paraskevas, Damas José, Viala Benjamin, Assal Frédéric, Tshikung Olivier Nawej, Tarr Philip X00a0 E, Derfuss Tobias, Oberholzer Michael, Jelcic Ilijas, Hundsberger Thomas, Sacco Leonardo, Cavassini Matthias, Du Pasquier Renaud A, Darling Katharine Elizabeth Anna, NAMACO Study Group, Swiss HIV Cohort Study

Zitation

Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K, NAMACO Study Group, Swiss HIV Cohort Study. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. J Acquir Immune Defic Syndr 2023; 93:219-228.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Acquir Immune Defic Syndr 2023; 93

Veröffentlichungsdatum

01.07.2023

eISSN (Online)

1944-7884

Seiten

219-228

Kurzbeschreibung/Zielsetzung

Despite modern antiretroviral therapy, human immunodeficiency virus-1 (HIV-1) ribonucleic acid (RNA) escape into the cerebrospinal fluid (CSF) may occur. We examined the prevalence of and factors associated with CSF HIV-1 escape among people living with HIV (PLWH) in Switzerland.